Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
The PP-based top and bottom webs are manufactured in a unique coextrusion process
The product is expected to be launched in June 2023
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Nous-209 has been developed using the Nouscom's viral vector platform
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
